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SEASONAL VARIATIONS OF THE OCCURRENCE OF ACUTE
MYOCARDIAL INFARCTION IN HUNGARY BETWEEN
2000–2004
Kriszbacher I1, Boncz I2, Oláh A1, Bódis J1
1University of Pécs, Pécs, Hungary, 2National Health Insurance Fund
Administration, Budapest, Hungary
OBJECTIVES: Although routinely collected data might have
some biases compared to professional registries or medical trials,
a health care ﬁnancing agency is interested in these administra-
tive date, because the ﬁnancing of health care institutions is
based on these administrative data. The purpose of this study
was to analyse the seasonal occurrence of acute myocardial
infarction (AMI) during the year on an administrative dataset.
METHODS: Data derive from the database of the National
Health Insurance Fund Administration, the one and only health
care ﬁnancing agency in Hungary, containing routinely collected
ﬁnancial data for the year 2002. Patients were selected with AMI
diagnosis with the I21 and I22 codes of the International Clas-
siﬁcation of Diseases (ICD), admitted to acute care hospitals in
2002. We extracted the time of hospital admission from hospi-
tal records and patients having more AMI during the year were
counted again. Our study provides a nation wide coverage of
Hungary for 2002. We calculated the average number of AMI
cases (incidence) per month with 95% conﬁdence interval. Sta-
tistical analysis as one-way analysis of variance (ANOVA) was
carried out with SPSS 14.0 for Windows. RESULTS: Altogether
N = 16,418 patients were included into the analysis. The daily
number of patient with AMI diagnosis proved to be the lowest
in July and August with average 38–39 cases per day. The highest
incidence was observed in March, April and May with an
average incidence of 49, 51, 49 cases per day respectively. Sta-
tistical analysis resulted in F = 4744 which is highly signiﬁcant
(p < 0.001) value. CONCLUSION: The occurrence of AMI
showed highly signiﬁcant seasonal variations within the year
2002 on our nationwide dataset. We emphasize the role of large
administrative databases in order to analyse “real word” data.
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METABOLIC SYNDROME PREVALENCE IN A HYPERTENSIVE
POPULATION
Shaya FT1, Gu A1, Saunders E2
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OBJECTIVES: To assess the prevalence of metabolic syndrome
in an urban, high risk, predominantly African American hyper-
tensive population. METHODS: The study is part of the NHLBI
U01 grant “Baltimore Partnership Programs to Reduce Cardio-
vascular Disparities”. Risk factors for metabolic syndrome were
assessed at baseline, and include risk factors of abdominal
obesity (BMI °Y´ 30), high triglycerides (triglycerides °Y´ 150
mg/dL), low HDL cholesterol (HDL < 40 mg/dL in men, or HDL
< 50 mg/dL in women), elevated blood pressure (BP °Y´ 130/85
mmHg), and elevated fasting glucose (blood glucose °Y´ 100
mg/dL) ¨C per American Diabetes Association criteria. We
assessed the number of patients with risk factors for metabolic
syndrome across race (Black vs. White patients) and gender, and
compared the average values of above indexes with metabolic
syndrome criteria. RESULTS: Out of a 321 patients, there were
17 white women, 17 white men, 191 black women and 96 black
men. By racial and gender groups, 4 White women (23.5%), 7
White men (41.2%), 33 Black women (17.3%) and 28 Black
men (29.2%) had 3 or more risk factors for Metabolic Syn-
drome. On average, study subjects are higher in BMI, blood
glucose level, blood pressures and HDL, and lower in triglyc-
erides level when compared with Metabolic Syndrome Criteria.
Black patients have higher BMI, systolic blood pressure, and
HDL and lower in triglycerides levels than their matched white
patients, however blood glucose levels are higher among whites.
Women have higher BMI and HDL, and lower blood glucose and
triglycerides levels than men. The differences are statistically sig-
niﬁcant (P < 0.05). CONCLUSION: Risk factors for metabolic
syndrome are highly prevalent in this urban high risk popula-
tion. Based on ADA criteria, black patients and women have
more risk factors for metabolic syndrome than whites and men,
respectively.
PCV14
SURVIVAL ANALYSIS OF PATIENTS WITH ACUTE
MYOCARDIAL INFARCTION ACCORDING TO HOSPITAL TYPE
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OBJECTIVES: Although routinely collected data might have
some biases compared to registries or medical trials, a health care
ﬁnancing agency is interested in these administrative data,
because the ﬁnancing of health care institutions is based on these
“real word” data. The purpose of this study was to analyse the
1 year survival rate after acute myocardial infarction (AMI)
according to the type of hospitals. METHODS: Data derive from
the database of the National Health Insurance Fund Adminis-
tration (OEP), the only health care ﬁnancing agency in Hungary,
containing routinely collected ﬁnancial data for the year 2004.
Patients were selected with AMI diagnosis with the I21 and I22
codes of the International Classiﬁcation of Diseases (ICD),
admitted to acute care hospitals in 2004. Statistical analysis was
carried out with SPSS 14.0 for Windows. We created Kaplan-
Meier survival curves and calculated chi-square values (Mantel-
Cox log rank test). RESULTS: Altogether N = 16,451 patients
were included into the analysis. We found the highest survival
rates at universities (80.5%, N = 2224) and national medical
institutes (81.6%, N = 904). The city hospitals (71.7%, N =
5216), county hospitals (69.5%, N = 5221) and the hospitals of
Budapest (68.1%, N = 2780) had similar survival rates. Some
special hospitals had the lowest (56.6%) survival rate, but the
number of patients (N = 106) was very low. The log rank test
resulted in a chi-square value of 168.711 with 5 degree of
freedom resulting in a signiﬁcant difference (P < 0.001). The
average age of patients was the lowest at universities but the dif-
ference was not statistically signiﬁcant. CONCLUSION: The
survival of patients depends on the type of hospital. We empha-
size the role of large administrative databases in order to analyse
“real word” data.
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NEW DIAGNOSIS OF HYPERTENSION AMONG CELECOXIB
AND NON-SELECTIVE NSAID USERS:A POPULATION-BASED
COHORT STUDY
Wang J1, Mullins CD1, Mamdani M2, Rublee DA2, Shaya FT1
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2Pﬁzer, Inc, New York, NY, USA
OBJECTIVES: The use of Nonsteroidal Anti-Inﬂammatory
Drugs (NSAIDs) has been associated with increased blood pres-
sure and hypertension. However, less is known about the risk of
hypertension associated with celecoxib, the only COX-2 selec-
tive inhibitor (coxib) available in the US market, in a real world
setting. The objective of this study is to compare the risk of inci-
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dent hypertension associated with the use of celecoxib and non-
selective (NS) NSAIDs in a real world setting. METHODS: A
cohort study was conducted using secondary data from the GE
Centricity® Electronic Medical Record database, which contains
the medical records of 3 million patients seen by 5000 physicians
in 27 states across the US. The index date was deﬁned as the
date of the ﬁrst NS NSAID or celecoxib prescription between
January 1, 1999 and June 30, 2004. Patients were included if
they were aged 18 or older and were enrolled for at least 365
days prior to the index date. NS NSAID users were matched to
celecoxib users using propensity-based matching techniques by
a 2 : 1 ratio. Multivariate Cox proportional hazard models were
used for the analysis. RESULTS: The ﬁnal sample consisted of
51,444 patients. Among the 17,148 celecoxib users, 222 (1.3%)
had a new diagnosis of hypertension, while 446 out of the
34,296 NS NSAID users (1.3%) had a new diagnosis of hyper-
tension. The crude incidence rate for hypertension was slightly
higher for celecoxib users: 52.5 vs. 51.8 per 1000 patient per
year for celecoxib and NS NSAID users, respectively. Relative to
NS NSAID users, patients on celecoxib had a similar rate of post
exposure hypertension incidence in multivariate analyses (HR =
1.006; 95% CI: 0.856–1.181). CONCLUSION: Results from a
population-based cohort analysis of electronic medical records
suggest similar rates of incident hypertension between celecoxib
and NS NSAID users.
CARDIOVASCULAR STUDIES—Cost Studies
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AN ECONOMIC ASSESSMENT OF THE CONTROL AND
DETENTION PROGRAMS IN HYPERTENSIVE MEXICAN
POPULATION (2005–2025)
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OBJECTIVES: To assess the economic impact in the Mexican
Health System of a hypertensive population preventive program
(HPPP) in order to shift cardiovascular risk on the long-term.
METHODS: Costs and health beneﬁts were forecasted for the
period 2005–2025 after the implementation of a control and
detention program in hypertensive population in Mexico. Inci-
dence and prevalence data was obtained from a Mexican
National Survey (Encuesta Nacional de Salud 2000) for popula-
tion between 20–59 yrs. Preventive actions included in the
program were: opportune detention of hypertension with two
measures of arterial hypertension per year to all adult popula-
tion attended in the Mexican Health System. Secondary preven-
tion actions consisted in changes in life styles and intensive
pharmacologic treatment in patients with uncontrolled hyper-
tension. Health care costs data was obtained from the Social
Security Mexican Institute (IMSS) databases and the HPPP effec-
tiveness was taken from published literature for worldwide
similar preventive programs. Framingham tables were used to
constructed disease progression simulations and effectiveness
measures used in the assessment were the number of new cases
of patients controlled and cardiovascular events avoided. The
analysis was conducted from the health care payer’s perspective
(only direct medical costs were used). RESULTS: Through 20-
years analysis period, the total number of hypertensive cases
remained unchanged. Nevertheless, the number of new hyper-
tensive cases controlled increased in 74.8% which represented a
reduction of 6.6 millions cases uncontrolled. On the same time
horizon, the HPPP showed a decrease of 16.9% in the total
number of cardiovascular events which represented approxi-
mately 1.7 millions less complications in the Mexican Health
System. The latter could represent in the future net savings in
US$1652 millions compared to the actual scenario. CONCLU-
SION: Preventive actions included in control and detention
hypertensive programs resulted to be cost-effectiveness policies,
and showed to be cost saving strategies in the long-term.
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COMPARING THE COST OF MICROSURGERY AND
RADIOSURGERY FOR THE MANAGEMENT OF VESTIBULAR
SCHWANNOMA
Banerjee R, Moriarty J, Pollock B, Foote R
Mayo Clinic, Rochester, MN, USA
OBJECTIVES: To investigate differences in follow-up costs of
patients undergoing microsurgical resection, which requires hos-
pitalization, compared to steriotactic radiosurgery, an outpatient
procedure, for the treatment of vestibular schwannoma.
METHODS: Post-surgical medical utilization records and cost
data were retrospectively gathered for 82 patients undergoing
microsurgery or radiosurgery. Follow-up costs were obtained
using administrative datasets and were discounted. Thirty-one
patients did not have any follow-up care at our facilities. For
patients seeking follow-up care elsewhere utilization records
(prospectively gathered) were matched to our administrative
costs using median values. To adjust for varying lengths of
follow-up, the cohort was reduced to those having a minimum
length of follow-up of 28 months. Results were veriﬁed with 36
months of follow up. RESULTS: In the initial cohort, age and
patient location were signiﬁcantly associated with surgery type.
Radiosurgery patients tended to be older. Mean costs per month
using a six month moving average for microsurgery patients ini-
tially were high and leveled off to below $200 per month. Con-
versely mean follow-up costs for radiosurgery patients started
low and ﬂuctuated through high and low cycles, reaching as high
as $200 per month. CONCLUSIONS: Many of the radiosurgery
patients did not have follow-up at our facility so we estimated
them from surgery-related follow-up utilization. In addition,
radiosurgery is a relatively new procedure and clinicians are not
yet in agreement on a reasonable length of follow-up. Including
other health care costs for these patients and accounting for
longer follow-up length would likely increase the mean follow-
up costs of radiosurgery further relative to microsurgery. This
may make the total cost (the sum of initial and follow-up costs)
of the two procedures more comparable.
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PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS:
A COST-EFFECTIVENESS ANALYSIS COMPARING MAGNETIC
RESONANCE ANGIOGRAPHY WITH DIGITAL SUBTRACTION
ANGIOGRAPHY
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OBJECTIVES: A decision analytic model was created to
compare the potential economic beneﬁts (cost-offsets and cost-
effectiveness) of treatment planning for peripheral arterial
disease (PAD) with either digital subtraction angiography (DSA)
and magnetic resonance angiography (MRA) technology in a
diabetic population. METHODS: The model considered degree
of stenosis, outcomes associated with a treatment plan, risk of
complications from DSA and MRA, and associated costs of
treatment. Sensitivity and speciﬁcity for DSA, considered the
